title: Fibrosing colonopathy associated with treatment with enteric-coated mesalazine pills.
authors.forename: Gerardo
authors.initials: G
authors.lastname: Prieto
authors.forename: Begoña
authors.initials: B
authors.lastname: Pérez-Moneo
authors.forename: Manuel
authors.initials: M
authors.lastname: Molina
authors.forename: Esther
authors.initials: E
authors.lastname: Ramos
authors.forename: Jesús
authors.initials: J
authors.lastname: Sarría
authors.forename: Javier
authors.initials: J
authors.lastname: Larrauri
authors.forename: Juan Antonio
authors.initials: JA
authors.lastname: Tovar
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002648:Child; D003093:Colitis, Ulcerative / Q000139:chemically induced* / Q000188:drug therapy; D003106:Colon / Q000473:pathology*; D003113:Colonoscopy; D005355:Fibrosis / Q000139:chemically induced; D006801:Humans; D008297:Male; D019804:Mesalamine / Q000009:adverse effects*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine